Spinal Non-Fusion Devices Market to Expand at a Substantial CAGR of 5.51% Reaching USD 1.51 Billion by 2026, Estimates DelveInsight

The demand for Spinal Non-Fusion Devices is primarily being boosted by major factors such as the increasing incidences of spinal disorders, the growing geriatric population base, advantages of Spinal Non-Fusion procedures over fusion procedures. Technical innovations in product development are also leading to an overall rise in the Spinal Non-Fusion Devices market

LAS VEGAS, March 14, 2022 /PRNewswire/ -- DelveInsight's Spinal Non-Fusion Devices Market Insights and Forecast report provides the current and forecast Spinal Non-Fusion Devices Market, upcoming innovation in the devices, individual market shares, challenges, drivers, and barriers, market growth trends, and key competitors in the Spinal Non-Fusion Devices Market. 

Some of the salient features from the Spinal Non-Fusion Devices Market report: 

• As per an analysis by DelveInsight, in terms of revenue share, North America is predicted to register the fastest growth in the Spinal Non-Fusion Devices market.
• Key Spinal Non-Fusion Devices companies proactively working in the market include Stryker, NuVasive Inc, Medtronic, Zimmer Biomet, ATEC Spine, Inc, B. Braun Melsungen,  SIGNUS Medizintechnik GmbH, Aditus Medical, RTI Surgical, Orthofix Medical Inc, Premia Spine, Globus Medical, SpineSave AG, Centinel Spine®, LLC, AxioMed LLC., Spinal Stabilization Technologies Ltd, SpineVision, Norm Medical Devices Co. Ltd., Neuro France Implants, Ackermann Medical GmbH & Co. KG, and others.
• DelveInsight analyzes that the Global Spinal Non-Fusion Devices Market USD 1.10 billion in 2020, growing at a CAGR of 5.51% during the forecast period from 2021 to 2026 to reach USD 1.51 billion by 2026. 
• In August 2021, Orthofix Medical Inc announced the first patient implant in the M6-C Artificial Cervical Disc Two-Level investigation device exemption (IDE) Study. The M6-C artificial cervical disc was FDA-approved for single-level implantation from C3 to C7 in 2019. It is indicated as an alternative to cervical fusion.
• In June 2021, Neo Medical received FDA 510(k) clearance for their Pedicle Screw System in the treatment of late-stage tumor indications to be used in combination with BonOs® Inject cement from OSARTIS. The company also received the CE mark approval for the same device.
• In May 2021, Spinal Stabilization Technologies Ltd received the Breakthrough Designation for PerQ disc Nucleus Replacement System for degenerative disc disease. The device also received the CE mark approval. PerQdisc is the only commercially available lumbar nucleus replacement system in the Global Spinal Non-Fusion Devices Market.
• In April 2021, NuVasive Inc received the 510k FDA approval for their two-level cervical total disc replacement- Simplify Disc. 
• On August 23, 2019, ApiFix, Ltd. had received FDA approval for a minimally invasive surgery Spinal Non-Fusion Device namely  Minimally Invasive Deformity Correction (MID-C) System.
• Centinel Spine, LLC launched the Angled Endplate implants for the prodisc® L Lumbar Total Disc Replacement System which have been designed to shift the lordotic angle of the implant to the inferior endplate thereby allowing surgeons to address the varied lumbar anatomy and pathology of patients.
• Hence, the above-mentioned recent breakthroughs and approvals in the Spinal Non-Fusion Devices Market serve as potential drivers which are expected to increase the growth in the Global Spinal Non-Fusion Devices Market.

To pick on the latest highlights related to Spinal Non-Fusion Devices, get the snapshot of the key highlights entailed in the Spinal Non-Fusion Devices Report

Spinal Non-Fusion Devices Overview 

Spinal Non-Fusion Devices are medical devices that are employed in the correction of anatomical surgical defects of the spine using a non-fusion approach. Spinal Non-Fusion Devices are used by surgeons during surgery for treatment of deformity, stabilization, and strengthening of the spine and for promoting fusion. In general, spinal surgery devices are categorized into fusion and non-fusion devices. The major difference between both types of devices is that fusion devices are combined with bone graft and non-fusion devices are used without bone graft. The devices replace pro-inflammatory tissues, repair the spinal alignment and decompress neural elements while maintaining functional movements. The devices are inserted into the patient's body without fusion in the human body and help in the stability and movement of patients after the surgery. Some examples of Spinal Non-Fusion Devices are growth sparing devices and artificial discs.

Spinal Non-Fusion Devices Market Insight 

Geographically, the global Spinal Non-Fusion Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the global market and is expected that it will remain constant during the forecast period. This domination is owing to the growing demand because of the high prevalence of spinal injuries, rising population of people suffering from spinal disorders such as degenerative disc diseases, lower back pain, and leg pain, rising product launch, and well-established reimbursement scenario for Spinal Non-Fusion Devices in the region among other factors in the region.

Furthermore, the prompt and well-established healthcare services and infrastructure contributes to the growth of the regional spinal fusion devices market growth. Moreover, the presence of key players in the region and supportive reimbursement programs further provide immense growth opportunities for the Spinal Non-Fusion Devices market. For instance, on April 01, 2020, OrthoPediatrics Corp. announces the acquisition of ApiFix Ltd. with FDA- approved non-fusion scoliosis technology.

Click here to understand more about the Spinal Non-Fusion Devices Market Forecast @ Spinal Non-Fusion Devices Future Assessment

Spinal Non-Fusion Devices Market Dynamics 

The Spinal Non-Fusion Devices market is witnessing a growth in product demand due to various reasons, one of them being the rising prevalence of spinal disorders. The demand for Spinal Non-Fusion Devices is primarily being boosted by the growing geriatric population base, Spinal Non-Fusion Devices advantages over spinal-fusion devices, and technical innovation in product development. Therefore, the constant technological advancements coupled with added advantages and product versatility of dynamic stabilization devices among other product types are expected to propel the growth of the Spinal Non-Fusion Devices market. Additionally, the rising geriatric population in the region has a higher susceptibility to spinal cord disorders such as degenerative disc diseases and others, along with rising healthcare costs, improving healthcare infrastructure population, and growing healthcare expenditure are further projected to augment the Spinal Non-Fusion Devices market in the region. 

The COVID-19 pandemic had a profound impact on elective and non-urgent surgeries across the countries. The demand for Spinal Non-Fusion Devices is primarily affected by the outbreak of the COVID-19 pandemic. The government imposed lockdowns to curb the spread of the virus leading to restrictions in movement and a decrease in regular check-ups. Owing to the COVID-19 pandemic situation, various forms of elective procedures were temporarily stopped in contrast to the COVID-19 affected patients that were given utmost priority. This led to a decrease in the requirement of surgery serving as an obstacle in the Spinal Non-Fusion Devices market.

To gain a better understanding of the COVID-19 impact on Spinal Non-Fusion Devices, get a snapshot of the COVID-19 Impact On Spinal Non-Fusion Devices 

Scope of the Spinal Non-Fusion Devices Market Report

• Coverage: Global
• Study Period: 2021-2026
• Market Segmentation By Product Type - Artificial Disc [Lumbar and Cervical], Dynamic Stabilization Devices, Facet Replacement Products, and Others
• Market Segmentation By Application- Spinal Stenosis, Degenerative Disc Diseases, Spondylolisthesis, and Others
• Market Segmentation By End-User- Hospitals, Specialty Clinics, and Others
• Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of the World
• Key Spinal Non-Fusion Devices Companies -  Stryker, NuVasive Inc, Medtronic, Zimmer Biomet, ATEC Spine, Inc, B. Braun Melsungen, SIGNUS Medizintechnik GmbH, Aditus Medical, RTI Surgical, Orthofix Medical Inc, Premia Spine, Globus Medical, SpineSave AG, Centinel Spine®, LLC, AxioMed LLC., Spinal Stabilization Technologies Ltd, SpineVision, Norm Medical Devices Co. Ltd., Neuro France Implants, Ackermann Medical GmbH & Co. KG, and others.
• Porter's Five Forces Analysis
• Product Profiles
• Case Studies 
• KOL's Views
• Analyst's View

Delveinsight Analysis: Global Spinal Non-Fusion Devices Market was valued at USD 1.10 billion in 2020, growing at a CAGR of 5.51% during the forecast period from 2021 to 2026 to reach USD 1.51 billion by 2026. 

Know more about which MedTech player is set to emerge as the trendsetter @ Key Spinal Non-Fusion Devices Companies Analysis 

Table of Contents 

Learn more about the report offerings @ Spinal Non-Fusion Devices Market Outlook

Related Reports

Vagus Nerve Stimulator Market

"DelveInsight's 'Vagus Nerve Stimulator Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Vagus Nerve Stimulator (VNS) and the historical and forecasted Vagus Nerve Stimulator (VNS) market trends, market drivers & barriers, unmet needs, and key Vagus Nerve Stimulator companies involved such as tVNS Technologies, Parasym Ltd, BioControl Medical, ElectroCore Inc, LivaNova PLC, Medtronic Plc, Boston Scientific Corporation, Aleva Neurotherapeutics SA, EnteroMedics Inc, and many others.

Peripheral Nerve Stimulators Pipeline

DelveInsight's, "Peripheral Nerve Stimulators Pipeline Insight and Competitive Landscape, 2022," report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Peripheral Nerve Stimulators (PNS) pipeline landscape such as Medline Industries Inc, Boston Scientific Corporation, Vygon SA, ElectroCore Inc, Enteromedics, Avanos Pain Management, NeuroMetrix Inc, NeuroSigma Inc, B. Braun Melsungen AG, IDS Medical Systems, Medtronic, St. Jude Medical, Xavant Technology (Pvt) Ltd, and many others.

Spinal Implants Market

The global Spinal Implants Market was valued at USD 12.35 billion in 2020, growing at a CAGR of 5.37% during the forecast period from 2021 to 2026 to reach USD 16.88 billion by 2026. The report delivers an in-depth understanding of Spinal Implants and the historical and forecasted Spinal Implants market trends, market drivers, market barriers, and key companies involved such as Orthofix Medical Inc, XTANT MEDICAL, RTI Surgical, Life Spine, Globus Medical, Captiva Spine, Medacta International, ATEC Spine, Inc, Advin Health Care, Auxein Medical, and others.

Deep Brain Stimulation Devices Market 

DelveInsight's 'Deep Brain Stimulation Devices Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of Deep Brain Stimulation Devices and the historical and forecasted Deep Brain Stimulation Devices market trends in the 7MM, market drivers, market barriers, and key Deep Brain Stimulation Devices companies involved like Boston Scientific Corporation, Medtronic, Inc, St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc, Neuronetics, Aleva Neurotherapeutics SA, Functional Neuromodulation Ltd, Beijing PINS Medical Co., Ltd, NeuroPace Inc, Nevro Corporation, and others.

Spinal Cord Stimulators Market 

DelveInsight's 'Spinal Cord Stimulators Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of Spinal Cord Stimulators and the historical and forecasted Spinal Cord Stimulators market trends in the 7MM, market drivers, market barriers, and key Spinal Cord Stimulators companies involved like Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Nevro Corp., Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., and others.

Top Trending DelveInsight Reports

• Primary Progressive Aphasia Market
• Zollinger-Ellison Syndrome Market
• Pyelonephritis Market
• Pheochromocytoma Market
• Advanced liver market
• Coronary stents pipeline
• Impetigo market
• Varicella-zoster HHV 3 infections market

Interested to know more about the breakthrough happenings? Take a look at the posts below 

• Spinal Stenosis Devices Market Size to Balloon Up Owing to Increasing Prevalence & Geriatric Population
• Spinal Muscular Atrophy: Current and Emerging Therapies

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Connect With Us at LinkedIn | Facebook | Twitter

Contact Us
Shruti Thakur 
info@delveinsight.com
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg